Pneumococcal Conjugate Vaccine (PCV) for elderly adults 60 years old and above
Cycle 1 | VaccinesHTA Council Preliminary Recommendation (as of 27 March 2026)
As a final recommendation, the HTA Council recommends the government financing of pneumococcal polysaccharide vaccine (PPSV23) for all adults 60 years old and above.
Relevant Information
- Status: with Preliminary HTA Council Recommendation
- Topic Assignment: External Assessment
- Policy Question: Should PCV-13 or PCV-15 as sequential vaccination with PPSV23 vs. PPSV23 alone for the immunization of all elderly adults 60 years old and above against diseases caused by Streptococcus pneumoniae be recommended for government financing?
- Secretary of Health Decision: Approved as of 18 June 2026
Evidence and Relevant Documents